Saudi Pharmaceutical Industries and Medical Appliances Corporation
2070.SRSAUHealthcare● Active
$28.50
$-0.40(-1.38%)
Market Cap$3.4B
P/E Ratio—
52W High$33.12
52W Low$22
Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 2070.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.18B | $0.03B | ($0.01B) | ($0.15B) | $0.03B |
| Depreciation & Amort. | $0.10B | $0.09B | $0.08B | $0.09B | $0.09B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.05B) | ($0.38B) | ($0.27B) | $0.00B | $0.01B |
| Net Cash from Operations | $0.27B | ($0.33B) | $0.05B | ($0.12B) | $0.09B |
| Investing Activities | |||||
| Capital Expenditure | ($0.09B) | ($0.07B) | ($0.12B) | ($0.08B) | ($0.08B) |
| Purchases of Investments | ($0.15B) | ($0.04B) | ($0.07B) | ($0.04B) | ($0.15B) |
| Sales of Investments | $0.13B | $0.00B | $0.00B | $0.57B | $0.34B |
| Net Cash from Investing | ($0.09B) | ($0.09B) | ($0.17B) | $0.48B | $0.14B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.01B) | ($0.01B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | ($0.00B) | ($0.00B) | ($0.07B) | ($0.12B) |
| Debt Issued / Repaid | ($0.10B) | $0.40B | $0.04B | ($0.21B) | ($0.06B) |
| Net Cash from Financing | ($0.10B) | $0.38B | ($0.03B) | ($0.31B) | ($0.24B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.18B | ($0.40B) | ($0.07B) | ($0.21B) | $0.00B |
| FCF Margin %(computed) | 10.73% | -23.66% | -4.21% | -14.64% | 0.19% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Saudi Pharmaceutical Industries and Medical Appliances Corporation data
About Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) Cash Flow Statement
Saudi Pharmaceutical Industries and Medical Appliances Corporation generated operating cash flow of $0.27B and free cash flow of $0.18B for 2025 — a FCF margin of 10.73%. Capital expenditure was ($0.09B).
Frequently asked questions
2070.SR · 4 questionsSaudi Pharmaceutical Industries and Medical Appliances Corporation generated free cash flow of $0.18B for 2025, up 146.0% year-over-year.
2070.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15